Wang Xin, Guo Zhao, Zhang Chenyang, Zhu Shuang, Li Lele, Gu Zhanjun, Zhao Yuliang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety Institute of High Energy Physics Chinese Academy of Sciences Beijing 100049 China.
College of Materials Science and Optoelectronic Technology University of Chinese Academy of Sciences Beijing 100049 China.
Adv Sci (Weinh). 2020 Jan 16;7(6):1902561. doi: 10.1002/advs.201902561. eCollection 2020 Mar.
Emerging strategies involving nanomaterials with high-atomic-number elements have been widely developed for radiotherapy in recent years. However, the concern regarding their potential toxicity caused by long-term body retention still limits their further application. In this regard, rapidly clearable radiosensitizers are highly desired for practical cancer treatment. Thus, in this work, ultrasmall BiOI quantum dots (QDs) with efficient renal clearance characteristic and strong permeability inside solid tumor are designed to address this issue. Additionally, considering that injection methods have great influence on the biodistribution and radiotherapeutic efficacy of radiosensitizers, two common injection methods including intratumoral injection and intravenous injection are evaluated. The results exhibit that intratumoral injection can maximize the accumulation of radiosensitizers within a tumor compared to intravenous injection and further enhance radiotherapeutic efficacy. Furthermore, the radiosensitizing effect of BiOI QDs is revealed, which is not only attributed to the radiation enhancement of high- elements but also is owed to the •OH production via catalyzing overexpressed HO within a tumor by BiOI QDs under X-ray irradiation. As a result, this work proposes a treatment paradigm to employ ultrasmall radiosensitizers integrated with local intratumoral injection to realize rapid clearance and high-efficiency radiosensitization for cancer therapy.
近年来,涉及含高原子序数元素的纳米材料的新兴放疗策略得到了广泛发展。然而,由于长期留存体内可能产生的潜在毒性问题,仍然限制了它们的进一步应用。在这方面,对于实际的癌症治疗而言,迫切需要可快速清除的放射增敏剂。因此,在本研究中,设计了具有高效肾清除特性且在实体瘤内部具有强渗透性的超小BiOI量子点(QDs)来解决这一问题。此外,考虑到注射方式对放射增敏剂的生物分布和放射治疗效果有很大影响,评估了两种常见的注射方式,即瘤内注射和静脉注射。结果表明,与静脉注射相比,瘤内注射可使放射增敏剂在肿瘤内的蓄积最大化,并进一步提高放射治疗效果。此外,揭示了BiOI量子点的放射增敏作用,这不仅归因于高原子序数元素的辐射增强,还归因于在X射线照射下BiOI量子点通过催化肿瘤内过表达的HO产生•OH。因此,本研究提出了一种治疗模式,即采用与局部瘤内注射相结合的超小放射增敏剂,以实现癌症治疗中的快速清除和高效放射增敏。